CAV 200 Pill - beige capsule/oblong, 14mm
Generic Name: capivasertib
Pill with imprint CAV 200 is Beige, Capsule/Oblong and has been identified as Truqap 200 mg. It is supplied by AstraZeneca.
Truqap is used in the treatment of Breast Cancer and belongs to the drug class multikinase inhibitors. Truqap 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CAV 200
Truqap
- Generic Name
- capivasertib
- Imprint
- CAV 200
- Strength
- 200 mg
- Color
- Beige
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-9501
More about Truqap (capivasertib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.